Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Cash from Investing Activities: 2019-2024

Historic Cash from Investing Activities for P3 Health Partners (PIII) over the last 6 years, with FY2024 value amounting to $14.5 million.

  • P3 Health Partners' Cash from Investing Activities fell 10079.33% to -$119000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$69000.0, marking a year-over-year decrease of 10046.0%. This contributed to the annual value of $14.5 million for FY2024, which is 89501.92% up from last year.
  • According to the latest figures from FY2024, P3 Health Partners' Cash from Investing Activities is $14.5 million, which was up 89501.92% from -$1.8 million recorded in FY2023.
  • In the past 5 years, P3 Health Partners' Cash from Investing Activities ranged from a high of $14.5 million in FY2024 and a low of -$8.2 million during FY2021
  • Moreover, its 5-year median value for Cash from Investing Activities was -$3.2 million (2020), whereas its average is -$1.3 million.
  • In the last 5 years, P3 Health Partners' Cash from Investing Activities skyrocketed by 1790.57% in 2020 and then skyrocketed by 89501.92% in 2024.
  • Over the past 5 years, P3 Health Partners' Cash from Investing Activities (Annual) stood at -$3.2 million in 2020, then plummeted by 159.27% to -$8.2 million in 2021, then grew by 5.8% to -$7.7 million in 2022, then skyrocketed by 76.37% to -$1.8 million in 2023, then surged by 895.02% to $14.5 million in 2024.
  • Its Cash from Investing Activities stands at $14.5 million for FY2024, versus -$1.8 million for FY2023 and -$7.7 million for FY2022.